TDOC Teladoc Health, Inc. Common Stock
Teladoc Health, Inc. Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Teladoc Health, Inc. is an American telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services.
Devamını oku
Teladoc Health, Inc. is an American telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services.
The company uses telephone and videoconferencing software and mobile apps to provide on-demand remote medical care. Teladoc Health is active in over 175 countries, and is traded on the New York Stock Exchange. It is the first and largest telemedicine company in the United States, and has acquired numerous other companies including BetterHelp in 2015, Best Doctors in 2017, and Catapult Health in 2025.
History
2002–2015
Teladoc was founded in 2002 in Dallas, Texas by G. Byron Brooks and Michael Gorton. It is the oldest and largest telemedicine company in the United States. Teladoc's initial business model allowed patients to remotely consult with state-licensed doctors at any time. Companies paid a monthly fee for their employees to access the service, while patients paid a flat fee for each consultation, originally about $35 to $40. With Gorton as both chairman and CEO, Teladoc launched nationally in 2005 at the Consumer Directed Health Care Conference in Chicago, Illinois. Teladoc had around 1 million members by the end of 2007, with large employers such as AT&T providing the service to employees as a health benefit. Jason Gorevic was named Teladoc's chief executive in 2009. In 2011, Aetna began offering Teladoc for its fully insured members in Florida and Texas, later offering Teladoc in all 50 states.
Teladoc acquired Consult A Doctor for $16.6 million cash in 2013, allowing smaller companies to access Teladoc's services. The Affordable Care Act led to a large number of insurance companies signing with Teladoc, resulting in a growth surge around 2014. By that time, insurance companies such as Blue Shield of California and Oscar had signed with Teladoc, as well as other companies such as Home Depot, T-Mobile, CalPERS, and Rent-A-Center. Teladoc acquired AmeriDoc for $17.2 million in May 2014. The acquisitions of Consult A Doctor and AmeriDoc, both Teladoc's main competitors, resulted in Teladoc becoming the largest telemedicine provider in the United States. After initial fundraising rounds in 2009, 2011, and 2013, Teladoc raised $50 million in 2014, bringing total funding to $100 million. Teladoc's sales doubled in both 2013 and 2014.
2015–2016
Teladoc Health became a public company on July 1, 2015 as the only telemedicine company on the New York Stock Exchange. Teladoc's initial public offering listed at $19 per share, giving the company a market capitalization of $758 million and an enterprise value of $620 million. The initial response to the IPO was positive, as shares surged 50% on the opening day. Three months after the IPO, health insurer Highmark, which represented 1.5% of Teladoc's 2015 revenue, ceased to renew a contract. Teladoc shares fell significantly as a result, before rising to earlier levels. That October, it was the first telehealth company to reach one million visits.
In 2015, Teladoc acquired the behavioral health services provider Compile Inc., operating as BetterHelp for $3.5 million, and competitor Stat Health Services (StatDoc) for $30 million. The following year Teladoc began aggressively expanding, acquiring other companies and launching health segments for dermatology, behavioral health, and sexual health. That year the company won a patent infringement lawsuit filed against competitor American Well.
In July 2016, Teladoc acquired HealthiestYou for $125 million ($45 million in cash and $80 million in stock). Teladoc had 15 million members by November 2016 and a market share of 75% in the United States. The largest national network of virtual care providers in the nation, its full-service suite was operational in 48 states, excluding Arkansas and Texas. In December 2016, the American Hospital Association exclusively endorsed Teladoc's telehealth technology platform. Teladoc logged 952,000 patient visits that year.
2017–2020
In its largest acquisition at the time, in 2017 Teladoc spent $440 million purchasing Best Doctors, a consultation firm and provider of medical second opinions and medical award listings. In 2019, ProPublica criticized companies such as Best Doctors for selling physician awards as pay-to-play. Teladoc had 7,500 clients in 2017, of which 220 were Fortune 1000 companies. Sales that year were $233 million, 89% higher than the year prior. Teladoc Health brands by 2018 included Teladoc, Advance Medical, Best Doctors, BetterHelp and HealthiestYou.
On August 10, 2018, Teladoc, Inc. changed its name to Teladoc Health, Inc. while continuing to trade on the NYSE. Teladoc Health began partnering with CVS in August 2018 on remote consults at MinuteClinics. Teladoc Health acquired Advance Medical, a telemedicine company employing doctors in Latin America, Europe, and Asia, for $352 million in 2018. In December 2018, Teladoc Health's chief financial officer and chief operating officer Mark Hirschhorn resigned after a report that he engaged in a sexual relationship and insider trading with an employee. According to Yahoo Finance, stock value fell roughly 20% in the days following, while an investor class action lawsuit alleged that Teladoc Health had violated securities laws by failing to disclose Hirschhorn's behavior. Teladoc Health denied making false statements or any legal violations.
Active in 130 countries by 2019; that year, Teladoc acquired the French health company MédecinDirect and launched in Canada with the Teladoc Telemedicine Service. Joining from American Express, Mala Murthy was appointed CFO in June 2019.
In March 2020, Teladoc was providing "near real-time" surveillance data on the spread of coronavirus to the CDC. In July 2020, Teladoc acquired InTouch Health. In October 2020, Teladoc acquired the chronic care company Livongo Health for $13.9 billion in a deal described by the press as the third-largest for a U.S. company that year. The combined companies had an estimated enterprise value of $37 billion. Teladoc then brought in Florida Blue as the first insurer to use Livongo's digital diabetes program. Teladoc sued Amwell in October 2020 for alleged copyright infringement on nine patents, settling the case in July 2022.
2021–2024
In early 2021, paid membership in the U.S. was 52 million. In January 2021, Teladoc began offering a diabetes management service through Dexcom. Later that year, Teladoc Health launched myStrength Complete, a "unified mental health care platform for its B2B customers." In June 2021, Teladoc sued the company Avail for allegedly infringing on three patents related to telemedicine consoles.
On July 14, 2021, Teladoc announced it was collaborating with Microsoft to combine its delivery platform for hospitals and health systems with Microsoft Teams. Teladoc introduced its primary care service Primary360 on a national scale in October 2021. The program gave members access to both a primary physician and care team, with a system in place for followup reminders about appointments and personal maintenance. In February 2022, Teladoc Health launched Chronic Care Complete, a program to help patients manage multiple chronic conditions.
Teladoc had a valuation of roughly $11.3 billion by February 2022, and warned investors there might be a goodwill write-down that year related to the Livongo acquisition. Teladoc announced that Amazon could newly access Teladoc through Alexa and related devices, in February 2022, sparking debate among antitrust experts about the potential impact on the health industry. Amazon Care was shut down later that year.
In April 2022, Northwell Health began using the Teladoc platform with its clinicians, starting with 20 hospitals in the system. After Teladoc's stock value fluctuated significantly during the coronavirus pandemic, the company, in June 2022, was sued by investors alleging it had misrepresented its financial prospects, particularly in regard to its BetterHelp mental health subsidiary and chronic care business. Characterizing the lawsuit, which was later dismissed, as "frivolous," in July 2022, Teladoc reported revenue growth above analysts' projections, with significant growth in BetterHelp. In August 2022, Teladoc became the telehealth portal for Mayo Clinic Health System patients in Onalaska, Wisconsin.
In 2023, the company relocated its headquarters to new York City. Charles "Chuck" Divita, III, was appointed CEO in June 2024, leading the company's further expansion. In July, the firm launched Wellbound employee assistance program (EAP), incorporating BetterHelp into its U.S. employer-sponsored health plans.
2025–present
In January 2025, the company added its virtual cardiometabolic programs to Amazon Health Services health benefits connector. That year, Teladoc Health made a series of acquisitions, including Catapult Health in February, mental healthcare company UpLift in April, and Australia's Telecare virtual care firm in August.
In March 2025, the FTC fined BetterHelp $7.8 million for sharing consumer data with third-party social media sites, banning the company from health data disclosures for advertising purposes. Subsequent to the dismissed June 2022 lawsuit, a new class-action was filed by investors in the U.S. District Court for the Southern District of New York on May 17, 2025.
The company reported over 100 million U.S. members in July 2025, and launched new AI capabilities for healthcare workplaces to monitor and mitigate violence that October. In November, Teladoc Health joined with Lumeris, Deloitte, Nuna and Unite Us as Collaborative for Healthy Rural America, pledging to build a shared, integrated care platform, following individual states' plan approvals from the new Rural Health Transformation (RHT) Program of the U.S. Department of Health and Human Services.
Services and business model
Headquartered in New York City, the company operates two main components: Teladoc Health Integrated Care, its virtual care business for health plans, employers and health networks, and BetterHelp direct-to-consumer virtual mental health care. As a technology company, Teladoc Health is involved with artificial intelligence, analytics, telehealth devices, and "licensable platform services." The company uses telephone and videoconferencing software to provide on-demand remote medical care, with patients able to log on to the service at any time and be connected with a board-certified, state-licensed physician. Its app combines all of its services and programs.
Contracting largely with insurers and large employers, hospitals and health systems, Teladoc Health generates revenue through an annual, or monthly, fee charged per subscriber, as well as a fee for individual consults. Some companies waive or subsidize the consult fee for their employees.
By July 2020, the company stated it served "60 of the top 100 hospitals," with telemedical robots being used at hospitals such as Providence Regional Medical Center in Everett, Washington and Sheba Medical Center in Israel, minimizing the potential spread of coronavirus. Numerous studies analyzing Teladoc's impact on the industry have been conducted.
Disaster aid
Teladoc Health provides free telehealth visits to communities affected by federally declared natural disasters and public emergencies in the United States, including to victims of incidents such as the 2018 Camp Fire in Paradise, California, Hurricane Ida in 2021, and the 2025 Southern California wildfires. In March 2023, it began providing free care to residents in Mississippi affected by recent tornadoes and, in 2024, to communities in several states that were impacted by Hurricanes Milton and Helene.
Lobbying and legislation
Teladoc Health has been involved in lobbying for legislation in several states. In 2015 the Texas Medical Board ruled that state physicians had to physically meet patients before remotely treating ailments or prescribing medication. The bill undermined Teladoc Health's business model in Texas, where it had around two million subscribers. Teladoc Health sued in federal court over the rule in Teladoc v. Texas Medical Board, arguing the bill violated antitrust laws by inflating prices and limiting the supply of health care providers in the state. The bill, meant to go active on June 3, 2015, was stalled while the lawsuit went through a federal appeals court, allowing Teladoc Health to continue operating in Texas in the interim. Teladoc voluntarily dropped the lawsuit in 2017 after Texas passed a new bill allowing for remote treatment without a prior in-person interaction, which Teladoc Health had lobbied heavily for.
In January 2019, Teladoc Health opposed a telemedicine bill proposed by the North Dakota Board of Medicine, which required telemedicine providers to perform initial video examinations or have initial exams done by another physician. Proponents argued the bill protected patients, while Teladoc Health and critics argued it decreased access to healthcare in rural areas. The year prior, Teladoc Health had completed 1,500 virtual visits in the state. In May 2019, the company created a virtual care patient safety organization (PSO) dubbed the Institute for Patient Safety and Quality of Virtual Care.
In December 2021, Teladoc along with the American Medical Association, American Hospital Association, AARP, Amazon, Walmart, and CVS formed Telehealth Access for America, a coalition pushing for the extension of telehealth policies implemented by U.S. Congress in response to the COVID-19 pandemic. Subsequently, U.S. Senators Bill Cassidy and Tammy Baldwin introduced the Health Data Use and Privacy Commission Act in February 2022, which proposes creating a commission to study modernizing health data and privacy laws. The proposed legislation was supported by Teladoc and organizations such as the American College of Cardiology, IBM, and the United Spinal Association.
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
TDOC Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
TDOC Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
TDOC Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
- Güçlü Al 4 12,9%
- Al 7 22,6%
- Tut 20 64,5%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
19 analist · 2026-08-14Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $-0.21 | $-0.25 | 0.04% |
| 31 Mart 2026 | $-0.36 | $-0.32 | -0.04% |
| 31 Aralık 2025 | $-0.14 | $-0.19 | 0.05% |
| 30 Eylül 2025 | $-0.28 | $-0.27 | -0.01% |
| 30 Haziran 2025 | $-0.19 | $-0.27 | 0.08% |
| 31 Mart 2025 | $-0.53 | $-0.34 | -0.19% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| TDOC | $1.25B | -6.1 | -1.5% | -7.9% | -14.3% | — |
| HTFL | $2.49B | -9.2 | 39.9% | -66.3% | 39.3% | 76.8% |
| SDGR | — | -12.7 | 23.3% | -40.4% | -29.2% | 55.7% |
| GDRX | — | 30.1 | 0.57% | 3.8% | 4.8% | — |
| CERT | $1.40B | -881.0 | 8.8% | -0.38% | -0.15% | — |
| HSTM | $682M | 37.8 | 4.3% | 6.0% | 5.2% | — |
| PHR | — | 335.8 | 14.5% | 0.48% | 0.73% | — |
| CTEV | $708M | -2.5 | 3.7% | -29.4% | 265.9% | — |
| EVH | — | -0.8 | -26.6% | -28.5% | -81.5% | — |
| VEEV | $33.40B | 37.5 | 16.3% | 28.4% | 13.1% | 75.5% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 18
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.53B | $2.57B | $2.60B | $2.41B | $2.03B | $1.09B | $553M | $418M | $233M | $123M | $77M | $44M | |
| Cost of Revenue | · | · | · | $744M | $650M | $391M | $184M | $129M | $62M | $32M | $21M | $10M | |
| Gross Profit | · | · | · | · | · | · | · | $289M | $172M | $91M | $56M | $34M | |
| R&D Expense | $278M | $307M | $349M | $334M | $312M | $165M | $65M | $54M | $34M | $22M | $14M | $8M | |
| SG&A Expense | $432M | $435M | $465M | $450M | $438M | $507M | $164M | $117M | $80M | $49M | $43M | $18M | |
| Operating Expenses | $2.79B | $3.59B | $2.85B | $16.06B | $2.30B | $1.60B | $634M | $489M | $309M | · | · | · | |
| Operating Income | $-263M | $-1.02B | $-249M | $-13.65B | $-266M | $-506M | $-80M | $-71M | $-75M | $-63M | $-56M | $-15M | |
| Interest Expense | · | $24M | $22M | $22M | $81M | · | · | · | · | · | · | · | |
| Interest Income | $37M | $57M | $47M | $13M | $776.0K | · | · | · | · | · | · | · | |
| Other Non-op | $10M | $-6M | $4M | $-859.0K | $5M | $-545.0K | $342.0K | · | · | · | · | · | |
| Pretax Income | $-236M | $-994M | $-220M | $-13.66B | $-385M | $-576M | $-109M | $-97M | $-107M | $-74M | $-58M | $-17M | |
| Income Tax | $-35M | $8M | $760.0K | $-4M | $44M | $-91M | $-11M | $118.0K | $-225.0K | $510.0K | $36.0K | $388.0K | |
| Net Income | $-200M | $-1.00B | $-220M | $-13.66B | $-429M | $-485M | $-99M | $-97M | $-107M | $-74M | $-58M | $-17M | |
| EPS (Basic) | $-1.14 | $-5.87 | $-1.34 | $-84.60 | $-2.73 | $-5.36 | $-1.38 | · | · | · | · | · | |
| EPS (Diluted) | $-1.14 | $-5.87 | $-1.34 | $-84.60 | $-2.73 | $-5.36 | $-1.38 | · | · | · | · | · | |
| Shares (Basic) | 176,221,530 | 170,564,088 | 164,578,219 | 161,457,123 | 156,939,349 | 90,509,229 | 71,844,535 | · | · | · | · | · | |
| Shares (Diluted) | 176,221,530 | 170,564,088 | 164,578,219 | 161,457,123 | 156,939,349 | 90,509,229 | 71,844,535 | · | · | · | · | · | |
| EBITDA | $-263M | $-1.02B | $-249M | $-13.40B | $-61M | $-437M | $-80M | $-35M | $-56M | · | $-51M | · |
Bilanço 28
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $781M | $1.30B | $1.12B | $918M | $893M | $733M | $514M | $424M | $43M | $50M | $55M | $46M | |
| Short-term Investments | · | · | · | · | · | · | · | $55M | $79M | $16M | $82M | · | |
| Receivables | $193M | $214M | $217M | $211M | $169M | $169M | $57M | $44M | $27M | $14M | $12M | $7M | |
| Inventory | $38M | $38M | $30M | $56M | $73M | $56M | $0 | · | · | · | · | · | |
| Prepaid Expense | $107M | $113M | $118M | $130M | $87M | $47M | $14M | $11M | $7M | $3M | $2M | $966.0K | |
| Other Current Assets | $2M | $3M | $7M | $12M | $6M | · | · | · | · | · | · | · | |
| Current Assets | $1.12B | $1.66B | $1.49B | $1.32B | $1.23B | $1.06B | $588M | $533M | $156M | $83M | $152M | $54M | |
| PP&E (Net) | $27M | $29M | $32M | $30M | $27M | $29M | $10M | $10M | $9M | $7M | $6M | $1M | |
| PP&E (Gross) | $112M | $101M | $92M | $77M | $61M | $51M | $26M | $22M | $17M | $12M | $8M | $2M | |
| Accum. Depreciation | $85M | $71M | $60M | $48M | $34M | $22M | $16M | $12M | $8M | $4M | $2M | $1M | |
| Goodwill | $283M | $283M | $1.07B | $1.07B | $14.50B | $14.58B | $746M | $737M | $499M | $188M | $56M | $28M | |
| Intangibles | $1.30B | $1.43B | $1.68B | $1.84B | $1.91B | $2.02B | $225M | $247M | $160M | $25M | $15M | $8M | |
| Other Non-current Assets | $106M | $81M | $80M | $49M | $21M | $18M | $7M | $1M | $858.0K | $415.0K | $293.0K | $296.0K | |
| Total Assets | $2.86B | $3.52B | $4.39B | $4.35B | $17.73B | $17.76B | $1.60B | $1.53B | $824M | $304M | $230M | $92M | |
| Accounts Payable | $48M | $33M | $44M | $48M | $47M | $46M | $9M | $8M | $4M | $2M | $2M | $2M | |
| Current Liabilities | $405M | $942M | $421M | $400M | $331M | $333M | $90M | $62M | $40M | $21M | $18M | $10M | |
| Capital Leases | $34M | $32M | $43M | $38M | $42M | $43M | $25M | $0 | · | · | · | · | |
| Deferred Tax | $29M | $50M | $49M | $51M | $76M | $102M | $22M | $32M | $13M | $2M | $1M | $482.0K | |
| Other Non-current Liabilities | $643.0K | $720.0K | $1M | $2M | $1M | $2M | $9M | $6M | $5M | $8M | $7M | $3M | |
| Total Liabilities | $1.47B | $2.03B | $2.07B | · | · | · | · | · | · | · | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | $44M | $26M | $26M | |
| Total Debt | · | · | · | · | $0 | $43M | · | · | · | · | $26M | · | |
| Common Stock | $178.0K | $173.0K | $167.0K | $163.0K | $160.0K | $150.0K | $73.0K | $70.0K | $61.0K | $46.0K | $38.0K | $2.0K | |
| Retained Earnings | $-16.43B | $-16.23B | $-15.23B | $-15.01B | $-1.42B | $-993M | $-508M | $-409M | $-312M | $-205M | $-131M | $-72M | |
| AOCI | $-35M | $-38M | $-37M | $-43M | $-6M | $19M | $-17M | $-13M | $4M | $-1.0K | $-42.0K | · | |
| Stockholders' Equity | $1.39B | $1.49B | $2.33B | $2.31B | $16.05B | $15.88B | $1.01B | $1.01B | $559M | $231M | $179M | $-68M | |
| Liabilities + Equity | $2.86B | $3.52B | $4.39B | $4.35B | $17.73B | $17.76B | $1.60B | $1.53B | $824M | $304M | $230M | $92M | |
| Shares Outstanding | 178,315,400 | 173,405,016 | 166,658,253 | 162,840,360 | 160,469,325 | 150,281,099 | 72,761,941 | 70,516,249 | 61,534,101 | 46,201,563 | 38,524,922 | 2,037,999 |
Nakit Akışı 18
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $256M | $204M | $69M | $39M | $36M | $19M | $8M | $5M | $2M | |
| Stock-based Comp | $80M | $146M | $202M | $218M | $303M | $476M | $67M | $44M | $31M | $8M | $3M | $533.0K | |
| Deferred Tax | $-41M | $-1M | $-2M | $-8M | $41M | $-91M | $-11M | $-2M | $-591.0K | $510.0K | $36.0K | $388.0K | |
| Amort. of Intangibles | $351M | $363M | $326M | $245M | $195M | $65M | $36M | $32M | $15M | $6M | $4M | $2M | |
| Restructuring | $19M | $20M | $17M | $7M | · | · | · | $1M | · | · | · | · | |
| Other Non-cash | · | · | · | $13.38B | $75M | $-23M | · | $15M | $23M | · | $3M | · | |
| Operating Cash Flow | $294M | $294M | $350M | $189M | $194M | $-54M | $30M | $-5M | $-34M | $-52M | $-47M | $-11M | |
| CapEx | $9M | $11M | $11M | $16M | $9M | $4M | $4M | $4M | $3M | $2M | $6M | $1M | |
| Investing Cash Flow | $-266M | $-124M | $-156M | $-168M | $-73M | $-591M | $25M | $-257M | $-448M | $26M | $-108M | · | |
| Debt Issued | · | · | · | · | · | · | · | $10.0K | $167M | $35M | $7M | $20M | |
| Net Debt Issued | · | · | · | · | · | · | $0 | $10.0K | $-60M | · | $468.0K | · | |
| Stock Issued | · | · | · | · | · | $0 | $0 | $331M | $259M | $250.0K | $163M | · | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $368.0K | |
| Net Stock Activity | · | · | · | · | · | $0 | $0 | $331M | $259M | · | · | · | |
| Financing Cash Flow | $-552M | $8M | $11M | $6M | $41M | $859M | $35M | $646M | $475M | $21M | $164M | · | |
| Taxes Paid | $9M | $9M | $7M | $3M | $4M | $1M | $1M | $441.0K | $137.0K | · | · | · | |
| Free Cash Flow | $285M | $283M | $339M | $173M | $185M | $-58M | $26M | $-9M | $-37M | · | $-53M | · | |
| Levered FCF | · | $259M | $316M | · | · | · | · | · | · | · | · | · |
Kârlılık 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 69.2% | 73.6% | · | 72.8% | · | |
| Operating Margin | -10.4% | -39.7% | -9.6% | -567.3% | -13.1% | -46.3% | -14.5% | -17.0% | -32.3% | · | -72.1% | · | |
| Net Margin | -7.9% | -39.0% | -8.5% | -567.5% | -21.1% | -44.4% | -17.9% | -23.2% | -45.8% | · | -75.0% | · | |
| Pretax Margin | -9.3% | -38.7% | -8.4% | -567.7% | -18.9% | -52.6% | -19.8% | -23.2% | -45.9% | · | -74.9% | · | |
| EBITDA Margin | -10.4% | -39.7% | -9.6% | -556.6% | -3.0% | -39.9% | -14.5% | -8.4% | -24.1% | · | -65.8% | · | |
| ROA | -6.3% | -25.3% | -5.0% | -123.7% | -2.4% | -5.0% | -6.3% | -8.2% | -18.9% | · | -36.1% | · | |
| ROE | -14.3% | -66.8% | -9.5% | -326.8% | -2.7% | -5.4% | -9.8% | -9.5% | -27.0% | · | -104.5% | · | |
| ROIC | -16.1% | -69.0% | -10.7% | -591.5% | -1.8% | -2.7% | -7.2% | -7.0% | -13.5% | · | -27.2% | · |
Likidite ve Solventlik 5
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.8 | 1.8 | 3.5 | 3.3 | 3.7 | 3.2 | 6.5 | 8.5 | 3.9 | · | 8.4 | · | |
| Quick Ratio | 2.4 | 1.6 | 3.2 | 2.8 | 3.2 | 2.7 | 6.3 | 8.4 | 3.7 | · | 8.3 | · | |
| Debt / Equity | · | · | · | · | 0.0 | 0.0 | · | · | · | · | 0.1 | · | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | 0.1 | · | |
| Interest Coverage | · | -42.9 | -11.2 | · | · | · | · | · | · | · | · | · |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.6 | 0.6 | 0.2 | 0.1 | 0.1 | 0.4 | 0.4 | 0.4 | · | 0.5 | · | |
| Inventory Turnover | · | · | · | 11.5 | 10.0 | 13.8 | · | · | · | · | · | · | |
| Receivables Turnover | 12.4 | 11.9 | 12.2 | 12.7 | 12.0 | 9.7 | 11.0 | 11.8 | 11.4 | · | 8.2 | · |
Büyüme Oranları 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -1.5% | -1.3% | 8.1% | 18.4% | 85.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 1.7% | 8.1% | 33.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 18.3% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 13
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.53B | $2.57B | $2.60B | $2.41B | $2.03B | $1.09B | $553M | $418M | $233M | $123M | $77M | · | |
| Net Income TTM | $-200M | $-1.00B | $-220M | $-13.66B | $-429M | $-485M | $-99M | $-97M | $-107M | $-74M | $-58M | · | |
| Market Cap | $1.25B | $1.58B | $3.59B | $3.85B | $14.73B | $30.05B | $6.09B | $3.50B | $2.14B | · | $692M | · | |
| Enterprise Value | · | · | · | · | $13.84B | $29.36B | · | · | · | · | $581M | · | |
| P/E | -6.1 | -1.5 | -16.1 | -0.3 | -33.6 | -37.3 | -60.7 | · | · | · | · | · | |
| P/S | 0.5 | 0.6 | 1.4 | 1.6 | 7.2 | 27.5 | 11.0 | 8.4 | 9.2 | · | 8.9 | · | |
| P/B | 0.9 | 1.1 | 1.5 | 1.7 | 0.9 | 1.9 | 6.0 | 3.5 | 3.8 | · | 3.9 | · | |
| P / Cash Flow | 4.2 | 5.4 | 10.3 | 20.3 | 76.0 | -561.6 | 203.9 | -719.2 | -62.3 | · | -14.7 | · | |
| P / FCF | 4.4 | 5.6 | 10.6 | 22.3 | 79.4 | -522.3 | 231.1 | -394.0 | -57.8 | · | -12.9 | · | |
| EV / EBITDA | · | · | · | · | -225.4 | -67.2 | · | · | · | · | -11.4 | · | |
| EV / FCF | · | · | · | · | 74.6 | -510.3 | · | · | · | · | -10.9 | · | |
| EV / Revenue | · | · | · | · | 6.8 | 26.8 | · | · | · | · | 7.5 | · | |
| Earnings Yield | -16.3% | -64.6% | -6.2% | -357.7% | -3.0% | -2.7% | -1.7% | · | · | · | · | · |
Gelir Tablosu 17
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $607M | $614M | $642M | $626M | $632M | $629M | $640M | $641M | $642M | $646M | $661M | $660M | $652M | $629M | $638M | $611M | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | · | · | $191M | $190M | · | $186M | |
| R&D Expense | $63M | $68M | $72M | $68M | $69M | $70M | $77M | $72M | $77M | $81M | $90M | $84M | $87M | $87M | $83M | $85M | |
| SG&A Expense | $104M | $102M | $108M | $103M | $108M | $113M | $100M | $114M | $110M | $112M | $109M | $116M | $126M | $114M | $120M | $112M | |
| Operating Expenses | $644M | $676M | $678M | $678M | $686M | $750M | $689M | $685M | $1.48B | $733M | $696M | $725M | $724M | $706M | $4.45B | $683M | |
| Operating Income | $-37M | $-62M | $-36M | $-52M | $-54M | $-121M | $-48M | $-44M | $-841M | $-87M | $-35M | $-65M | $-72M | $-77M | $-3.82B | $-72M | |
| Interest Expense | · | · | · | · | · | $6M | · | $6M | $6M | $6M | · | $6M | $6M | $5M | $5M | $6M | |
| Interest Income | $6M | $6M | $7M | $7M | $10M | $13M | $14M | $15M | $14M | $14M | $14M | $13M | $12M | $9M | $6M | $5M | |
| Other Non-op | $-2M | $-196.0K | $378.0K | $-815.0K | $8M | $2M | $-7M | $2M | $-563.0K | $-370.0K | $2M | $-2M | $-207.0K | $5M | $2M | $-2M | |
| Pretax Income | $-38M | $-61M | $-34M | $-50M | $-40M | $-111M | $-48M | $-32M | $-834M | $-79M | $-25M | $-60M | $-66M | $-69M | $-3.81B | $-75M | |
| Income Tax | $997.0K | $3M | $-8M | $-715.0K | $-8M | $-18M | $238.0K | $780.0K | $4M | $3M | $4M | $-2M | $-952.0K | $681.0K | $-2M | $-1M | |
| Net Income | $-39M | $-64M | $-25M | $-50M | $-33M | $-93M | $-48M | $-33M | $-838M | $-82M | $-29M | $-57M | $-65M | $-69M | $-3.81B | $-73M | |
| EPS (Basic) | $-0.21 | $-0.36 | $-0.14 | $-0.28 | $-0.19 | $-0.53 | $-0.27 | $-0.19 | $-4.92 | $-0.49 | $-0.17 | $-0.35 | $-0.40 | $-0.42 | $-23.35 | $-0.45 | |
| EPS (Diluted) | $-0.21 | $-0.36 | $-0.14 | $-0.28 | $-0.19 | $-0.53 | $-0.27 | $-0.19 | $-4.92 | $-0.49 | $-0.17 | $-0.35 | $-0.40 | $-0.42 | $-23.35 | $-0.45 | |
| Shares (Basic) | 181,026,004 | 179,122,268 | -350,784,759 | 176,934,781 | 175,917,380 | 174,154,128 | -338,892,523 | 171,496,282 | 170,229,583 | 167,730,746 | -327,635,223 | 165,119,379 | 164,171,372 | 162,922,691 | -322,180,835 | 161,727,962 | |
| Shares (Diluted) | 181,026,004 | 179,122,268 | -350,784,759 | 176,934,781 | 175,917,380 | 174,154,128 | -338,892,523 | 171,496,282 | 170,229,583 | 167,730,746 | -327,635,223 | 165,119,379 | 164,171,372 | 162,922,691 | -322,180,835 | 161,727,962 | |
| EBITDA | $-37M | $-62M | · | $-52M | $-54M | $-121M | · | $-44M | $-841M | $-87M | · | $30M | $4M | $-7M | · | $-72M |
Bilanço 25
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $774M | $751M | $781M | $726M | $680M | $1.19B | $1.30B | $1.24B | $1.16B | $1.10B | · | $1.03B | $959M | $889M | · | $900M | |
| Receivables | $221M | $214M | $193M | $211M | $225M | $233M | $214M | $212M | $218M | $214M | · | $206M | $215M | $216M | · | $202M | |
| Inventory | $29M | $32M | $38M | $40M | $38M | $38M | $38M | $37M | $35M | $32M | · | $36M | $34M | $46M | · | $59M | |
| Prepaid Expense | $124M | $136M | $107M | $116M | $130M | $138M | $113M | $116M | $131M | $142M | · | $115M | $113M | $136M | · | $127M | |
| Other Current Assets | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $983.0K | $6M | $9M | · | $8M | $8M | $7M | · | $13M | |
| Current Assets | $1.15B | $1.13B | $1.12B | $1.09B | $1.07B | $1.60B | $1.66B | $1.61B | $1.55B | $1.49B | · | $1.39B | $1.32B | $1.29B | · | $1.29B | |
| PP&E (Net) | $25M | $26M | $27M | $27M | $28M | $31M | $29M | $28M | $29M | $30M | · | $33M | $30M | $30M | · | $27M | |
| PP&E (Gross) | · | · | $112M | · | · | · | $101M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $85M | · | · | · | $71M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $283M | $283M | $283M | $283M | $283M | $283M | $283M | $283M | $283M | $1.07B | $1.07B | $1.07B | $1.07B | $1.07B | · | $4.85B | |
| Intangibles | $1.18B | $1.24B | $1.30B | $1.34B | $1.38B | $1.39B | $1.43B | $1.50B | $1.55B | $1.61B | · | $1.73B | $1.78B | $1.82B | · | $1.85B | |
| Other Non-current Assets | $104M | $106M | $106M | $107M | $101M | $109M | $81M | $78M | $81M | $80M | · | $74M | $73M | $64M | · | $44M | |
| Total Assets | $2.76B | $2.81B | $2.86B | $2.88B | $2.89B | $3.44B | $3.52B | $3.53B | $3.52B | $4.32B | · | $4.33B | $4.32B | $4.31B | · | $8.10B | |
| Accounts Payable | $37M | $45M | $48M | $52M | $54M | $52M | $33M | $38M | $56M | $38M | · | $26M | $16M | $39M | · | $71M | |
| Current Liabilities | $1.38B | $405M | $405M | $405M | $402M | $952M | $942M | $931M | $931M | $389M | · | $403M | $383M | $381M | · | $411M | |
| Capital Leases | $30M | $32M | $34M | $38M | $32M | $34M | $32M | $37M | $38M | $40M | · | $34M | $37M | $36M | · | $41M | |
| Deferred Tax | $27M | $28M | $29M | $34M | $30M | $24M | $50M | $51M | $51M | $47M | · | $44M | $48M | $51M | · | $52M | |
| Other Non-current Liabilities | $700.0K | $551.0K | $643.0K | $4M | $4M | $4M | $720.0K | $736.0K | $1M | $1M | · | $2M | $2M | $2M | · | $2M | |
| Total Liabilities | $1.45B | $1.47B | $1.47B | $1.49B | $1.47B | $2.02B | $2.03B | $2.02B | $2.02B | · | · | · | · | · | · | · | |
| Common Stock | $182.0K | $180.0K | $178.0K | $177.0K | $177.0K | $175.0K | $173.0K | $172.0K | $171.0K | $169.0K | · | $166.0K | $165.0K | $164.0K | · | $162.0K | |
| Retained Earnings | $-16.53B | $-16.49B | $-16.43B | $-16.41B | $-16.36B | $-16.32B | $-16.23B | $-16.18B | $-16.15B | $-15.31B | · | $-15.20B | $-15.14B | $-15.08B | · | $-11.20B | |
| AOCI | $-34M | $-35M | $-35M | $-35M | $-35M | $-37M | $-38M | $-37M | $-39M | $-39M | · | $-42M | $-39M | $-41M | · | $-49M | |
| Stockholders' Equity | $1.31B | $1.34B | $1.39B | $1.39B | $1.42B | $1.43B | $1.49B | $1.51B | $1.50B | $2.29B | $2.33B | $2.29B | $2.30B | $2.29B | $2.31B | $6.05B | |
| Liabilities + Equity | $2.76B | $2.81B | $2.86B | $2.88B | $2.89B | $3.44B | $3.52B | $3.53B | $3.52B | $4.32B | · | $4.33B | $4.32B | $4.31B | · | $8.10B | |
| Shares Outstanding | 181,649,591 | 180,431,102 | 178,315,400 | 177,349,640 | 176,608,056 | 175,340,325 | 173,405,016 | 171,944,014 | 171,124,883 | 169,314,029 | 166,658,253 | 165,557,305 | 164,877,180 | 163,919,394 | 162,840,360 | 162,195,790 |
Nakit Akışı 12
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $94M | $75M | $70M | · | $62M | |
| Stock-based Comp | $9M | $15M | $16M | $17M | $22M | $25M | $27M | $34M | $42M | $42M | $47M | $53M | $56M | $46M | $51M | $56M | |
| Amort. of Intangibles | $88M | $90M | $92M | $86M | $89M | $84M | $87M | $87M | $95M | $95M | $95M | $92M | $73M | $67M | $83M | $49M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $6M | $411.0K | $3M | $8M | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $-33M | · | · | |
| Operating Cash Flow | $65M | $10M | $88M | $99M | $91M | $16M | $86M | $110M | $89M | $9M | $130M | $106M | $101M | $13M | $66M | $63M | |
| CapEx | $928.0K | $2M | $3M | $2M | $1M | $3M | $6M | $2M | $2M | $1M | $1M | $6M | $2M | $2M | $6M | $4M | |
| Investing Cash Flow | $-42M | $-37M | $-34M | $-49M | $-60M | $-123M | $-30M | $-31M | $-28M | $-36M | $-37M | $-38M | $-37M | $-46M | $-54M | $-41M | |
| Financing Cash Flow | $875.0K | $-2M | $1M | $-4M | $-550M | $769.0K | $2M | $698.0K | $4M | $2M | $-2M | $5M | $4M | $3M | $4M | $634.0K | |
| Taxes Paid | $3M | $-42.0K | $3M | $104.0K | $5M | $328.0K | $2M | $3M | $5M | $-245.0K | $921.0K | $6M | $439.0K | $346.0K | $2M | $337.0K | |
| Free Cash Flow | · | $8M | · | · | · | $13M | · | · | · | $8M | · | · | · | $11M | · | · | |
| Levered FCF | · | · | · | · | · | $8M | · | · | · | $2M | · | · | · | · | · | · |
Kârlılık 7
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -6.1% | -10.1% | · | -8.3% | -8.6% | -19.2% | · | -6.9% | -130.9% | -13.5% | · | -9.8% | -11.0% | -12.2% | · | -11.7% | |
| Net Margin | -6.4% | -10.4% | · | -7.9% | -5.2% | -14.8% | · | -5.2% | -130.4% | -12.7% | · | -8.6% | -10.0% | -11.0% | · | -12.0% | |
| Pretax Margin | -6.2% | -9.9% | · | -8.0% | -6.4% | -17.7% | · | -5.1% | -129.8% | -12.3% | · | -9.0% | -10.1% | -10.9% | · | -12.2% | |
| EBITDA Margin | -6.1% | -10.1% | · | -8.3% | -8.6% | -19.2% | · | -6.9% | -130.9% | -13.5% | · | 4.5% | 0.59% | -1.2% | · | -11.7% | |
| ROA | -1.4% | -2.0% | · | -1.6% | -1.0% | -2.4% | · | -0.85% | -21.4% | -1.9% | · | -0.92% | -1.1% | -0.90% | · | -0.57% | |
| ROE | -2.9% | -4.6% | · | -3.4% | -2.2% | -5.0% | · | -1.8% | -44.1% | -3.6% | · | -1.4% | -1.6% | -1.2% | · | -0.67% | |
| ROIC | -2.9% | -4.9% | · | -3.7% | -3.1% | -7.1% | · | -3.0% | -56.3% | -3.9% | · | -2.7% | -3.1% | -3.4% | · | -1.2% |
Likidite ve Solventlik 3
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 2.8 | · | 2.7 | 2.7 | 1.7 | · | 1.7 | 1.7 | 3.8 | · | 3.4 | 3.4 | 3.4 | · | 3.1 | |
| Quick Ratio | 0.7 | 2.4 | · | 2.3 | 2.3 | 1.5 | · | 1.6 | 1.5 | 3.4 | · | 3.1 | 3.1 | 2.9 | · | 2.7 | |
| Interest Coverage | · | · | · | · | · | -20.9 | · | -7.8 | -148.9 | -15.4 | · | -11.5 | -12.3 | · | · | · |
Verimlilik 3
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | · | · | · | 4.0 | 3.3 | · | 3.2 | |
| Receivables Turnover | 2.7 | 2.7 | · | 3.0 | 2.8 | 2.8 | · | 3.1 | 3.0 | 3.0 | · | 3.2 | 3.1 | 3.1 | · | 3.2 |
Değerleme (TTM) 9
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.48B | $2.50B | · | $2.53B | $2.54B | $2.56B | · | $2.59B | $2.60B | $2.59B | · | $2.55B | $2.49B | $2.40B | · | $2.29B | |
| Net Income TTM | $-185M | $-239M | · | $-208M | $-997M | $-1.05B | · | $-1.01B | $-1.04B | $-273M | · | $-265M | $-3.31B | $-9.92B | · | $-9.93B | |
| Market Cap | $1.54B | $983M | · | $1.37B | $1.54B | $1.40B | · | $1.58B | $1.67B | $2.56B | · | $3.08B | $4.17B | $4.25B | · | $4.11B | |
| P/E | -8.2 | -4.0 | · | -6.5 | -1.5 | -1.3 | · | -1.5 | -1.6 | -9.1 | · | -11.5 | -1.2 | -0.4 | · | -0.4 | |
| P/S | 0.6 | 0.4 | · | 0.5 | 0.6 | 0.5 | · | 0.6 | 0.6 | 1.0 | · | 1.2 | 1.7 | 1.8 | · | 1.8 | |
| P/B | 1.2 | 0.7 | · | 1.0 | 1.1 | 1.0 | · | 1.0 | 1.1 | 1.1 | · | 1.3 | 1.8 | 1.9 | · | 0.7 | |
| P / Cash Flow | · | 103.3 | · | · | · | 87.7 | · | · | · | 286.6 | · | · | · | 322.7 | · | · | |
| P / FCF | · | 125.2 | · | · | · | 105.8 | · | · | · | 329.0 | · | · | · | 393.4 | · | · | |
| Earnings Yield | -12.3% | -24.9% | · | -15.4% | -66.9% | -77.0% | · | -64.8% | -63.0% | -11.0% | · | -8.7% | -80.9% | -238.1% | · | -243.7% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $2.53B | $2.57B | $2.60B | $2.41B | $2.03B |
| Faaliyet Kâr Marjı % | -10.4% | -39.7% | -9.6% | -567.3% | -13.1% |
| Net Gelir | $-200M | $-1.00B | $-220M | $-13.66B | $-429M |
| Seyreltilmiş Hisse Başı Kâr | $-1.14 | $-5.87 | $-1.34 | $-84.60 | $-2.73 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | — | — | — | — | 0.0 |
| Cari Oran | 2.8 | 1.8 | 3.5 | 3.3 | 3.7 |
| Cari Oran | 2.4 | 1.6 | 3.2 | 2.8 | 3.2 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $285M | $283M | $339M | $173M | $185M |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 398 dosya · $1.2B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 73 (+11 önceki Ç'ye göre) | 33 (-40 önceki Ç'ye göre) | 104 (-10 önceki Ç'ye göre) | 88 (+3 önceki Ç'ye göre) | +36.3M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD GROUP INC | $139.930.938 | 19.990.134 | 11,50% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $107.573.820 | 12.685.592 | 8,84% | Hisse senetleri |
| Point72 Asset Management, L.P. | $69.874.581 | 8.239.927 | 5,74% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $68.457.700 | 8.072.842 | 5,63% | Hisse senetleri |
| Voss Capital, LP | $68.235.838 | 8.046.679 | 5,61% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $67.458.671 | 7.955.032 | 5,55% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $59.415.442 | 7.006.538 | 4,88% | Hisse senetleri |
| STATE STREET CORP | $42.080.999 | 4.962.382 | 3,46% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $41.505.394 | 4.894.504 | 3,41% | Hisse senetleri |
| Allianz Asset Management GmbH | $39.572.734 | 4.666.596 | 3,25% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $33.651.520 | 3.967.415 | 2,77% | Hisse senetleri |
| Monaco Asset Management SAM | $26.864.462 | 3.167.979 | 2,21% | Hisse senetleri |
| JUPITER ASSET MANAGEMENT LTD | $26.370.375 | 3.109.714 | 2,17% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $25.976.377 | 3.063.252 | 2,14% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $25.430.579 | 2.998.889 | 2,09% | Hisse senetleri |
| Quantinno Capital Management LP | $23.904.416 | 2.818.917 | 1,97% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $17.299.632 | 2.040.051 | 1,42% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $16.946.398 | 1.998.396 | 1,39% | Hisse senetleri |
| Pale Fire Capital SE | $16.737.502 | 1.973.762 | 1,38% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $16.435.088 | 1.938.100 | 1,35% | Alım opsiyonu |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11.710.032 | 1.380.900 | 0,96% | Satım opsiyonu |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $11.348.708 | 1.338.291 | 0,93% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $10.120.074 | 1.193.405 | 0,83% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $9.796.800 | 1.155.283 | 0,81% | Hisse senetleri |
| Freestone Grove Partners LP | $7.338.160 | 865.349 | 0,60% | Hisse senetleri |
| Man Group plc | $6.880.545 | 811.385 | 0,57% | Hisse senetleri |
| PRINCIPAL FINANCIAL GROUP INC | $6.795.228 | 801.324 | 0,56% | Hisse senetleri |
| CITADEL ADVISORS LLC | $6.795.024 | 801.300 | 0,56% | Satım opsiyonu |
| Union Square Park Capital Management, LLC | $6.784.000 | 800.000 | 0,56% | Hisse senetleri |
| CITADEL ADVISORS LLC | $6.532.093 | 770.294 | 0,54% | Hisse senetleri |
| FMR LLC | $6.418.334 | 756.879 | 0,53% | Hisse senetleri |
| TCW GROUP INC | $6.248.039 | 736.797 | 0,51% | Hisse senetleri |
| Voss Capital, LP | $5.936.000 | 700.000 | 0,49% | Alım opsiyonu |
| Empowered Funds, LLC | $5.764.619 | 679.790 | 0,47% | Hisse senetleri |
| PEAK6 LLC | $5.227.920 | 616.500 | 0,43% | Alım opsiyonu |
| CITADEL ADVISORS LLC | $5.114.288 | 603.100 | 0,42% | Alım opsiyonu |
| Squarepoint Ops LLC | $5.089.696 | 600.200 | 0,42% | Alım opsiyonu |
| JANE STREET GROUP, LLC | $5.088.848 | 600.100 | 0,42% | Satım opsiyonu |
| FRANKLIN RESOURCES INC | $4.518.161 | 532.802 | 0,37% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $4.211.319 | 601.617 | 0,35% | Hisse senetleri |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $3.700.706 | 436.404 | 0,30% | Hisse senetleri |
| WOLVERINE TRADING, LLC | $3.607.180 | 439.900 | 0,30% | Alım opsiyonu |
| Parallax Volatility Advisers, L.P. | $3.392.000 | 400.000 | 0,28% | Alım opsiyonu |
| TUDOR INVESTMENT CORP ET AL | $3.288.603 | 387.807 | 0,27% | Hisse senetleri |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $3.248.866 | 383.121 | 0,27% | Hisse senetleri |
| Swiss National Bank | $3.035.857 | 358.002 | 0,25% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $2.894.928 | 341.383 | 0,24% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $2.781.435 | 510.355 | 0,23% | Hisse senetleri |
| Squarepoint Ops LLC | $2.761.936 | 325.700 | 0,23% | Satım opsiyonu |
| Trexquant Investment LP | $2.755.932 | 324.992 | 0,23% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $2.544.000 | 300.000 | 0,21% | Satım opsiyonu |
| ORACLE INVESTMENT MANAGEMENT INC | $2.480.366 | 354.338 | 0,20% | Hisse senetleri |
| Soviero Asset Management, LP | $2.442.240 | 288.000 | 0,20% | Alım opsiyonu |
| D. E. Shaw & Co., Inc. | $2.371.941 | 279.710 | 0,20% | Hisse senetleri |
| BlackRock, Inc. | $2.312.106 | 272.654 | 0,19% | Hisse senetleri |
| IEQ CAPITAL, LLC | $2.273.165 | 268.062 | 0,19% | Hisse senetleri |
| JANE STREET GROUP, LLC | $2.155.616 | 254.200 | 0,18% | Alım opsiyonu |
| WOLVERINE TRADING, LLC | $2.059.020 | 251.100 | 0,17% | Satım opsiyonu |
| RHUMBLINE ADVISERS | $2.058.803 | 242.785 | 0,17% | Hisse senetleri |
| Walleye Trading LLC | $2.017.188 | 237.876 | 0,17% | Hisse senetleri |
| WINTON GROUP Ltd | $1.925.808 | 227.100 | 0,16% | Hisse senetleri |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $1.906.796 | 224.858 | 0,16% | Hisse senetleri |
| Brevan Howard Capital Management LP | $1.880.084 | 221.708 | 0,15% | Hisse senetleri |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $1.704.675 | 243.525 | 0,14% | Hisse senetleri |
| UBS Group AG | $1.696.000 | 200.000 | 0,14% | Alım opsiyonu |
| NOMURA HOLDINGS INC | $1.696.000 | 200.000 | 0,14% | Satım opsiyonu |
| Parker Investment Management, LLC | $1.586.515 | 187.089 | 0,13% | Hisse senetleri |
| OPPENHEIMER & CO INC | $1.571.268 | 185.291 | 0,13% | Hisse senetleri |
| ABS Direct Equity Fund LLC | $1.513.154 | 178.438 | 0,12% | Hisse senetleri |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1.495.703 | 274.441 | 0,12% | Hisse senetleri |
| Summit Trail Advisors, LLC | $1.488.766 | 175.562 | 0,12% | Hisse senetleri |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $1.484.000 | 175.000 | 0,12% | Hisse senetleri |
| SIMPLEX TRADING, LLC | $1.396.808 | 164.718 | 0,11% | Hisse senetleri |
| BARCLAYS PLC | $1.347.861 | 158.946 | 0,11% | Hisse senetleri |
| NATIXIS | $1.347.472 | 158.900 | 0,11% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $1.346.183 | 158.748 | 0,11% | Hisse senetleri |
| JENNISON ASSOCIATES LLC | $1.333.793 | 157.287 | 0,11% | Hisse senetleri |
| Rock Creek Group LLC | $1.329.944 | 156.833 | 0,11% | Hisse senetleri |
| MACKENZIE FINANCIAL CORP | $1.297.381 | 152.993 | 0,11% | Hisse senetleri |
| Walleye Trading LLC | $1.277.936 | 150.700 | 0,11% | Satım opsiyonu |
| Counterpoint Mutual Funds LLC | $1.252.301 | 147.677 | 0,10% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $1.233.111 | 145.414 | 0,10% | Hisse senetleri |
| Balyasny Asset Management L.P. | $1.226.208 | 144.600 | 0,10% | Satım opsiyonu |
| TWO SIGMA INVESTMENTS, LP | $1.217.245 | 143.543 | 0,10% | Hisse senetleri |
| ALGERT GLOBAL LLC | $1.211.792 | 142.900 | 0,10% | Hisse senetleri |
| Engineers Gate Manager LP | $1.204.499 | 142.040 | 0,10% | Hisse senetleri |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1.187.666 | 140.055 | 0,10% | Hisse senetleri |
| Walleye Capital LLC | $1.082.896 | 127.700 | 0,09% | Alım opsiyonu |
| Leonteq Securities AG | $1.064.384 | 125.517 | 0,09% | Hisse senetleri |
| VANGUARD ASSET MANAGEMENT, Ltd | $1.045.813 | 123.327 | 0,09% | Hisse senetleri |
| JANUS HENDERSON GROUP PLC | $1.038.988 | 190.640 | 0,09% | Hisse senetleri |
| Walleye Capital LLC | $989.616 | 116.700 | 0,08% | Satım opsiyonu |
| Crawford Fund Management, LLC | $987.072 | 116.400 | 0,08% | Satım opsiyonu |
| OP Asset Management Ltd | $958.969 | 113.086 | 0,08% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $932.469 | 109.961 | 0,08% | Hisse senetleri |
| CHIRON CAPITAL MANAGEMENT, LLC | $930.850 | 109.770 | 0,08% | Hisse senetleri |
| Jefferies Financial Group Inc. | $907.657 | 107.035 | 0,07% | Hisse senetleri |
| MetLife Investment Management, LLC | $901.746 | 106.338 | 0,07% | Hisse senetleri |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $891.845 | 96.104 | 0,07% | Hisse senetleri |
| Y-Intercept (Hong Kong) Ltd | $876.815 | 103.398 | 0,07% | Hisse senetleri |
Şirket yöneticileri 48 içeriden öğrenenler · 23 yöneticiler · 22 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Charles Divita III | CHIEF EXECUTIVE OFFICER | 10 Haziran 2026 M | 414.622 | 0 | 6 | $-938.572 |
| Jason N Gorevic | Chief Executive Officer | 04 Mart 2022 M | 516.464 | 0 | 0 | $0 |
| Mala Murthy | Chief Financial Officer | 01 Mart 2022 A | 17.357 | 0 | 0 | $0 |
| Mark Hirschhorn | Executive VP, COO and CFO | 13 Aralık 2018 M | 10.000 | 0 | 0 | $0 |
| Kelly Bliss | President, U.S. Group Health | 06 Temmuz 2026 S | 84.878 | 0 | 4 | $-126.068 |
| Fernando M. Rodrigues | President of BetterHelp | 03 Haziran 2026 S | 0 | 0 | 2 | $-114.131 |
| Carlos Nueno | President, International | 01 Haziran 2026 M | 57.671 | 0 | 1 | $-47.257 |
| Peter A Mcclennen | President | 15 Temmuz 2019 M | 0 | 0 | 0 | $0 |
| David William Sides | Chief Operating Officer | 29 Temmuz 2021 M | 11.031 | 0 | 0 | $0 |
| Joseph Ronald Catapano | Chief Accounting Officer | 01 Temmuz 2026 M | 12.267 | 0 | 2 | $-8.108 |
| Adam C Vandervoort | CHIEF LEGAL OFFICER, SECRETARY | 01 Haziran 2026 M | 110.261 | 0 | 3 | $-241.831 |
| Daniel Trencher | SVP Corporate Strategy | 04 Mart 2022 M | 29.408 | 0 | 0 | $0 |
| Stephany Verstraete | Chief Marketing Officer | 04 Mart 2022 M | 31.828 | 0 | 0 | $0 |
| Andrew Turitz | SVP - Business Development | 04 Mart 2022 M | 14.794 | 0 | 0 | $0 |
| Claus Torp Jensen | Chief Innovation Officer | 01 Mart 2022 A | — | 0 | 0 | $0 |
| Arnnon Geshuri | Chief Human Resources Officer | 01 Mart 2022 A | 83.168 | 0 | 0 | $0 |
| Richard J Napolitano | Chief Accounting Officer | 01 Mart 2022 A | 1.195 | 0 | 0 | $0 |
| Lewis Levy | Chief Medical Officer | 01 Ekim 2020 M | 8.766 | 0 | 0 | $0 |
| Michelle Bucaria | Chief Human Resources Officer | 01 Eylül 2020 M | 3.232 | 0 | 0 | $0 |
| Christopher Caridi | Chief Accounting Officer | 01 Temmuz 2020 A | — | 0 | 0 | $0 |
| Gabriel R. Cappucci | Senior VP, Controller and CAO | 16 Nisan 2020 M | 988 | 0 | 0 | $0 |
| Michael H. King | Chief Sales Officer | 25 Mayıs 2017 A | 61.459 | 0 | 0 | $0 |
| Peter N. Nieves | EVP and CRO | 13 Mart 2017 A | — | 0 | 0 | $0 |
| Mark V Anquillare | Yönetim kurulu üyesi | 03 Ağustos 2026 A | — | 0 | 0 | $0 |
| David B Snow JR | Yönetim kurulu üyesi | 21 Mayıs 2026 A | 113.032 | 0 | 0 | $0 |
| David L Shedlarz | Yönetim kurulu üyesi | 21 Mayıs 2026 A | 61.266 | 0 | 0 | $0 |
| Susan R Salka | Yönetim kurulu üyesi | 30 Mart 2026 A | — | 0 | 0 | $0 |
| Catherine Jacobson | Yönetim kurulu üyesi | 18 Şubat 2022 M | 1.468 | 0 | 0 | $0 |
| William H. Frist | Yönetim kurulu üyesi | 15 Eylül 2021 M | 12.918 | 0 | 0 | $0 |
| Karen L Daniel | Yönetim kurulu üyesi | 25 Ağustos 2021 M | 41.915 | 0 | 0 | $0 |
| Christopher Bischoff | Yönetim kurulu üyesi | 25 Mayıs 2021 M | 5.121 | 0 | 0 | $0 |
| Mark Douglas Smith | Yönetim kurulu üyesi | 17 Mayıs 2021 A | 3.536 | 0 | 0 | $0 |
| Kenneth H Paulus | Yönetim kurulu üyesi | 17 Mayıs 2021 A | 0 | 0 | 0 | $0 |
| Thomas Mckinley | Yönetim kurulu üyesi | 17 Mayıs 2021 A | 5.879 | 0 | 0 | $0 |
| Hemant Taneja | Yönetim kurulu üyesi | 19 Nisan 2021 S | 118.760 | 0 | 0 | $0 |
| Glen Tullman | Yönetim kurulu üyesi | 01 Nisan 2021 M | 275.793 | 0 | 0 | $0 |
| Helen Darling | Yönetim kurulu üyesi | 11 Haziran 2020 M | 918 | 0 | 0 | $0 |
| Arneek Multani | Yönetim kurulu üyesi | 30 Mayıs 2019 A | 918 | 0 | 0 | $0 |
| Brian P Mcandrews | Yönetim kurulu üyesi | 30 Mayıs 2019 A | 1.965 | 0 | 0 | $0 |
| Tom Mawhinney | Yönetim kurulu üyesi | 25 Mayıs 2018 M | 46.203 | 0 | 0 | $0 |
| Martin R Felsenthal | Yönetim kurulu üyesi | 08 Ağustos 2016 A | 10.860 | 0 | 0 | $0 |
| Dana G Mead Jr. | Yönetim kurulu üyesi | 08 Ağustos 2016 A | 202 | 0 | 0 | $0 |
| James K Outland | Yönetim kurulu üyesi | 13 Temmuz 2015 M | 49.986 | 0 | 0 | $0 |
| CHP III Management, L.L.C. | 10% sahip | 26 Nisan 2017 J | 2.480.468 | 0 | 0 | $0 |
| CHP III LP | 10% sahip | 26 Nisan 2017 J | 2.480.468 | 0 | 0 | $0 |
| Sandra L Fenwick | — | 21 Mayıs 2026 A | 10.762 | 0 | 0 | $0 |
| Yulun Wang | — | 25 Ocak 2021 S | 219.507 | 0 | 0 | $0 |
| Michael Goldstein | — | 11 Haziran 2020 M | 0 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 2 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Kinnevik AB (publ), Invik S.A. ×3 başvurular | 15 Nisan 2021 | — | İlk başvuru | — | SEC |
| General Catalyst Group Management Holdings GP, LLC, General Catalyst Group Management Holdings, L.P., General Catalyst Group Management, LLC, General Catalyst Group VI, L.P., General Catalyst Partners VI, L.P., General Catalyst GP VI, LLC, General Catalyst Group VIII, L.P., General Catalyst Group VIII Supplemental, L.P., General Catalyst Partners VIII, L.P., General Catalyst GP VIII, LLC, GC Partners Holdings, LP, GCSE VIII, L.P., GCSE VIII, LLC, GCGM Investment Holdings, LP, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow, Hemant Taneja ×3 başvurular | 16 Mart 2021 | — | İlk başvuru | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 55 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| HEAL · Global X Funds | 1,18% | 38.782 NS | 31 Mayıs 2026 | N-PORT |
| SVAL · iShares Trust | 0,42% | 129.925 SH | 08 Ağustos 2026 | Günlük |
| JSML · Janus Detroit Street Trust | 0,34% | 178.607 NS | 30 Nisan 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,20% | 261.035 NS | 31 Mayıs 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,18% | 66.764 NS | 31 Mayıs 2026 | N-PORT |
| IHF · iShares Trust | 0,18% | 332.174 SH | 08 Ağustos 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,10% | 159.976 SH | 08 Ağustos 2026 | Günlük |
| SMLF · iShares Trust | 0,09% | 592.154 SH | 08 Ağustos 2026 | Günlük |
| FNDA · SCHWAB STRATEGIC TRUST | 0,08% | 978.669 NS | 31 Mayıs 2026 | N-PORT |
| AVUV · AMERICAN CENTURY ETF TRUST | 0,08% | 2.910.344 NS | 31 Mayıs 2026 | N-PORT |
| IWN · iShares Trust | 0,08% | 1.690.654 SH | 08 Ağustos 2026 | Günlük |
| GINN · Goldman Sachs ETF Trust | 0,08% | 21.242 NS | 31 Mayıs 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,07% | 920.742 NS | 30 Nisan 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,07% | 155.542 NS | 30 Nisan 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,07% | 252.145 NS | 31 Mayıs 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,06% | 67.673 NS | 30 Nisan 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 1.047.849 SH | 08 Ağustos 2026 | Günlük |
| VFMF · VANGUARD WELLINGTON FUND | 0,04% | 29.737 SH | 08 Ağustos 2026 | Günlük |
| IWM · iShares Trust | 0,04% | 4.666.989 SH | 08 Ağustos 2026 | Günlük |
| ISCV · iShares Trust | 0,04% | 38.629 SH | 08 Ağustos 2026 | Günlük |
| PNQI · Invesco Exchange-Traded Fund Trust | 0,04% | 26.986 SH | 08 Ağustos 2026 | Günlük |
| ITWO · ProShares Trust | 0,03% | 8.377 NS | 31 Mayıs 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 77.120 NS | 30 Nisan 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,03% | 2.631.374 SH | 08 Ağustos 2026 | Günlük |
| SCHA · SCHWAB STRATEGIC TRUST | 0,03% | 858.463 NS | 31 Mayıs 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,03% | 584.184 NS | 30 Nisan 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 2.084.219 SH | 08 Ağustos 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,02% | 4.153.113 SH | 08 Ağustos 2026 | Günlük |
| UWM · ProShares Trust | 0,02% | 6.552 NS | 31 Mayıs 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,02% | 535.056 SH | 08 Ağustos 2026 | Günlük |
| ISCB · iShares Trust | 0,02% | 7.717 SH | 08 Ağustos 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 81.058 NS | 30 Nisan 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,02% | 10.585 NS | 30 Nisan 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 6.629 NS | 31 Mayıs 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,01% | 285.019 NS | 30 Nisan 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,01% | 170.044 SH | 08 Ağustos 2026 | Günlük |
| WSML · iShares Trust | 0,01% | 10.387 SH | 08 Ağustos 2026 | Günlük |
| TILT · FlexShares Trust | 0,01% | 34.034 NS | 30 Nisan 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 6.863 NS | 31 Mayıs 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 166 NS | 31 Mayıs 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 422.235 NS | 30 Nisan 2026 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0,01% | 9.970 NS | 31 Mayıs 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,01% | 1.783 NS | 31 Mayıs 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 22.871 NS | 30 Nisan 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 11.743 NS | 30 Nisan 2026 | N-PORT |
| DSI · iShares Trust | 0,00% | 25.216 SH | 08 Ağustos 2026 | Günlük |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 42.456 NS | 31 Mayıs 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 105.579 NS | 31 Mayıs 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 232.888 SH | 08 Ağustos 2026 | Günlük |
| IWV · iShares Trust | 0,00% | 45.271 SH | 08 Ağustos 2026 | Günlük |